George Makol
Allergy & Immunology · Tucson, AZNPI 1568409761
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AstraZeneca at 29.4% of the total.
Across 403 payments — averaging $32.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- CSL Behring$2K
- GSK$2K
- Pharming Healthcare, Inc.$903
- Sanofi$857
- Regeneron Healthcare Solutions, Inc.$578
- plus $4K from 20 others
What the payments were for
- Consulting fees$190%
- Food & beverage$12,79499%
- Education$1301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 56 | $3,799 |
| CSL Behring | 50 | $1,545 |
| GSK | 85 | $1,516 |
| Pharming Healthcare, Inc. | 28 | $903 |
| Sanofi | 21 | $857 |
| Regeneron Healthcare Solutions, Inc. | 16 | $578 |
| Amgen | 7 | $477 |
| Novartis | 19 | $386 |
| Biocryst US Sales Co., LLC | 12 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $352 |
| Pfizer | 27 | $322 |
| Optinose US, Inc. | 8 | $308 |
| Grifols USA, LLC | 7 | $253 |
| Blueprint Medicines Corporation | 5 | $168 |
| Teva Pharmaceuticals USA, Inc. | 10 | $160 |
| Genentech USA, Inc. | 9 | $160 |
| Covis Pharma GmbH | 5 | $154 |
| Boehringer Ingelheim | 7 | $153 |
| Kaleo, Inc. | 7 | $150 |
| Shire North American Group Inc | 2 | $124 |
| Octapharma USA, Inc. | 2 | $69 |
| Cycle Pharmaceuticals Inc | 2 | $42 |
| Aerin Medical Inc. | 1 | $39 |
| LEO Pharma Inc. | 1 | $21 |
| ADMA Biomanufacturing LLC | 1 | $19 |
| USWM, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,944 in reported general payments places this provider in the 75th percentile of 90 allergy & immunology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 98 | $54,874 |
| XolairOmalizumab | 18 | $51,639 |
| Dupixent SyringeDupilumab | 11 | $41,915 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $34,594 |
| Arnuity ElliptaFluticasone Furoate | 80 | $29,977 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 114 | $21,973 |
| DuleraMometasone/Formoterol | 38 | $17,616 |
| SymbicortBudesonide/Formoterol Fumarate | 58 | $15,075 |
| Advair HfaFluticasone Propion/Salmeterol | 27 | $12,414 |
| Qvar RedihalerBeclomethasone Dipropionate | 46 | $11,049 |
| Advair DiskusFluticasone Propion/Salmeterol | 30 | $8,481 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,653 |
| Fluticasone Propionate HfaFluticasone Propionate | 21 | $6,081 |
| AlvescoCiclesonide | 13 | $5,485 |
| Wixela InhubFluticasone Propion/Salmeterol | 22 | $3,998 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $1,516 | $119,446225 claims |
| AstraZenecaSymbicort | $3,799 | $15,07558 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $160 | $11,04946 claims |
| Boehringer IngelheimSpiriva Respimat | $153 | $6,65313 claims |
| Covis Pharma GmbHAlvesco | $154 | $5,48513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Tucson
- Tara CarrTucson$76K
- Pierre SakaliTucson$25K
- Nicole LahoodTucson$13K
- Nabeeh LahoodTucson$13K
- Martin BartelsTucson$7K
- Puneet ShroffTucson$4K
- Kudagal MurthyTucson$3K
- Anjali JainTucson$2K
- Kaitlyn LeaheyTucson$1K
- Michael ManningScottsdale$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.